IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
pa nies. Prod uct ranges in clude: phar ma ceu ti cal
prod ucts (branded, unbranded, pre scrip tion,
non-pre scrip tion). Es tab lished 1999. 120 phar -
ma ceu ti cal employees in 2007.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 51-100 (2007)
Con tacts (Pharm): Com mer cial Op er a tions:
An gel Luis Ro dri guez De La Cuerda; Mar ket Re -
search: Elena Blanco Andreu
Sub sid iary of: Sandoz, Ger many
Phar ma ceu ti cal Sales: US$ 50-55 mil lion
Prod ucts (% of Sales by Lead ing 5): 30-35%
Ther a peu tic Classes (% of Sales by Lead ing
5): 55-60%
Dose Forms (% of Sales by Lead ing 5):
95-100%
Prin ci pal Prod ucts:
OMEPRAZOL BEX EFG (antiulcerant)
SIMVASTATINA BEXAL (cho les terol/triglyceride
reg u lat ing prep a ra tion)
ACETILCISTEINA BEX (ex pec to rant)
CITALOPRAM BEXAL (an ti de pres sant)
AMLODIPINO BEXAL (cal cium an tag o nist plain)
Ther a peu tic Range:
lipid-reg u lat ing/antiatheroma prep a ra tions
13%
ant ac ids/antiflatulents/antiulcerants 12%
psychoanaleptics 11%
antibacterials sys temic 10%
renin-an gio ten sin sys tem agents 10%
Lead ing Dose Forms:
tab lets 48%
coated tab lets 25%
cap sules 22%
pow ders/gran ules 2%
liq uids 2%
CIBA VI SION
Full Name: CIBA Vi sion S.A.
Street Ad dress: C/ Ma rina, 206-208, 08013
Bar ce lona
Tel: +34 93 306 47 00
Fax: +34 93 245 63 44
Home Page: www.cibavision.es
Sub sid iary of: Novartis, Swit zer land (100%)
NOVARTIS
Full Name: Novartis Farmaceutica SA
Postal Ad dress: Apartado 708, 08080 Bar ce lona
Street Ad dress: Gran Via de les Corts, Catalanes
764, 08013 Bar ce lona
Tel: +34 93 306 42 00
Fax: +34 93 306 44 12
Home Page: www.novartis.es
De scrip tion: Re searcher, de vel oper, man u fac -
turer, packager/as sem bler, pro moter,
sales/detailer. Prod uct ranges in clude: phar ma -
ceu ti cal prod ucts (branded, pre scrip tion), hos pi tal
pharmaceuticals, oph thal mic prod ucts.
Established 1997.
Con tacts (Pharm): Chair man: Je sus Acetillo;
Com mer cial Op er a tions: Juan Bigorra
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 950-1,000 mil lion
Prod ucts (% of Sales by Lead ing 5): 40-45%
Ther a peu tic Classes (% of Sales by Lead ing
5): 50-55%
Dose Forms (% of Sales by Lead ing 5):
85-90%
Prin ci pal Prod ucts:
GLIVEC (antineoplastic other)
CO DIOVAN (an gio ten sin-II an tag o nist com bi na -
tion)
DIOVAN (an gio ten sin-II an tag o nist plain)
ZOMETA (bone cal cium reg u la tor)
FEMARA (cytostatic hor mone an tag o nist)
Ther a peu tic Range:
antineoplastics 19%
renin-an gio ten sin sys tem agents 18%
immunosuppressive agents 6%
ophthalmologicals 5%
musculoskeletal drugs other 5%
Lead ing Dose Forms:
coated tab lets 49%
tab lets 15%
vi als 8%
cap sules 8%
liq uids 7%
NOVARTIS CON SUMER HEALTH
Full Name: Novartis Con sumer Health SA
Street Ad dress: Calle de la Ma rina, 206, 08013
Bar ce lona
Tel: +34 93 306 47 00
Fax: +34 93 306 47 01
Home Page: www.novartisconsumerhealth.es
De scrip tion: De vel oper, dis trib u tor, pro moter,
sales/detailer. Prod uct ranges in clude: phar ma -
ceu ti cal prod ucts (branded, pre scrip tion,
non-pre scrip tion). 158 phar ma ceu ti cal em ploy -
ees in 2008. Di vi sions include: OTC - BU.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 84 (2008)
Con tacts (Pharm): Chair man: Mick Clay ton;
Mar ket Re search: Bernat Subira; Re search & De -
© 2009 IMS Health In cor po rated or its af fil i ates Page 209